PUBLISHED : 27 Aug 2023 at 04:00
The Food and Drug Administration (FDA) is maintaining a wait and see stance after Japan’s release of wastewater from the crippled Fukushima nuclear plant into the Pacific Ocean on Aug 24, according to FDA deputy secretary-general Lertchai Lertvut.
Mr Lertchai said the FDA discussed inspections of imports from the region with the Department of Fisheries, the Office of Atoms for Peace and the Thailand Institute of Nuclear Technology (Tint) due to the risk of seafood becoming contaminated by the wastewater.
He said that officials from the fisheries department and the FDA will examine all food that arrives for traces of radioactive materials above Thailand’s safety threshold. The agencies will return any…
